Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-019757

Chief Executive Officer bought 1,160 shares at $6.89 ($7,987)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-03-14 Purchase : show line 1 in the form +1,160 $6.89 $7,987 59,935 D
Open-market purchases · 1,160 sh · avg $6.89 · $7,987
Loading xslF345X03/doc4.xml…